The observed performance of PP was also poor, but it did not reach statistical significance except in the detection of metastatic disease.
← all excerpts
Chromogranin a and pancreatic polypeptide are not suitable for the screening of pancreatic neuroendocrine tumors in MEN1 - a long-term follow-up study.
1
—
—